Artal Group S.A.

All Holdings — 2025 Q4

AI Portfolio Summary
In 2025 Q4, Artal Group S.A. maintained a portfolio of 2 distinct positions.
PCA Score Concentration Risk
Risk ENB
Total Positions
2
Quarter
2025 Q4
Top Holding
CAVA (78.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-2 of 2
Stock History Sector / Type Port % Prev % Rank / Prev Conviction Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
CAVA
Cava Group Inc
Consumer Cyclical 78.09% 75.75% #1
Prev: #1
10.0 no change no change
P
S
9,507,990 $558,023,933 2023 Q2 13F Filing 2025-12-31 2026-02-14 (Est.)
LXRX
Lexicon Pharmac...
Healthcare 21.91% 24.25% #2
Prev: #2
8.8 no change no change
P
S
136,180,481 $156,607,553 2015 Q2 13F Filing 2025-12-31 2026-02-14 (Est.)
Showing 1-2 of 2 holdings

Unlock Full Artal Group S.A. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics